IJO Instructions to Authors

General Information

International Journal of Ophthalmology (IJO) is an international ophthalmological academic publication and a peer-reviewed periodical (ISSN 1672-5123). This journal is sponsored by Xi’an Medical Association, China and obtains guidance and support from WHO and ICO/IFOS.

IJO is a Chinese-English mixed publication and it accepts contributions in English or Chinese from all over the world. It includes mainly original research articles and short research communications, both basic and clinical papers. It has been internationalized both in editorial committee and in contributions and has been indexed by "Chemical Abstracts" of America, "Abstract Journal" of Russia, Elsevier Bibliographic Databases of the Netherlands (EMBASE/Scopus) and the Source Journal for Chinese Scientific and Technical Papers and Citations (China Core Periodical of Science and Technology).

Manuscript Preparation

Manuscripts are received with the explicit understanding that they are not under simultaneous consideration by any other publication except in abstract form. Submission of an article for publication implies transfer of the copyright from the author to the publisher upon acceptance. Accepted papers become the permanent property of “IJO” and may not be reproduced by any means, in whole or in part, without the written consent of the publisher.

It is the author’s responsibility to obtain permission to reproduce illustrations, tables, etc. from other publications. Research involving live human and animal subjects must have been approved by the author’s institutional review board. IJO requires that in the Methods section of their manuscripts the authors state that they adhered to the tenets of the Declaration of Helsinki or the ARVO Statement for the use of Animals in Ophthalmic and Vision Research. All types of original articles should include the following:

Title page

It is the first page of your manuscript, on which you should indicate full manuscript title, running title, all author(s) name(s), affiliations, institution(s) and/or department(s) where the work was accomplished, author contributions; disclosure of any financial support for the research, and the name, full address with postal code, telephone and fax numbers and email address of the corresponding author should be included. Titles should be concise and informative(removing all unnecessary words), emphasize what is new and avoid abbreviations. List the author(s)’ name(s) as follows: initial and/or first name, middle name or initial(s), and full family name.

Abstract

An informative, structured abstract of no more than 350 words should accompany each manuscript. Abstracts for original contributions should be structured into the following sections: AIM: only the purpose should be included. METHODS: the materials, techniques, instruments, equipments, and the experimental procedures should be included. RESULTS: the observed and experimental results, including data, effects, outcomes, etc. should be included. Authors should present P value where necessary, and also include any significant data. CONCLUSION: accurate view and the value of results should be included.

Key Words

Please list 3 to 10 key words, selected mainly from Index Medicus, which reflect the content of the study.

Text

For original articles on either clinical science or laboratory science, the main text should be structured into the following sections: INTRODUCTION, MATERIALS AND METHODS, RESULTS and DISCUSSION, and should include appropriate Figures and Tables. Data should be presented in the body text or in Figures and Tables, but not in both.

All manuscripts are subjected to peer review and editorial approval before accepting for publication. All submissions must be typed in 1.5 line spacing and 12pt. font with ample margins. The preferred font is Times New Roman. In a brief Introduction, provide the research rationale and objectives without extensively reviewing the literature. In the Methods section, describe the experimental design, subjects used, and procedures followed; provide sufficient details to enable others to duplicate the research. Use standard chemical or pharmaceutical terms. In parentheses, identify specific sources by the name of company, city, or state of country. Present the Results with a minimum statistically significant data and their limitations. Do not reiterate results.

Illustrations

Figures should be numbered as 1, 2, 3 and so on, and mentioned clearly in the main text. Provide a brief title for each figure on a separate page. No detailed legend should be involved under the figures. This part should be added into the text where the figures are applicable.

Tables

Three-line tables should be numbered 1, 2, 3 and so on, and mentioned clearly in the main text. Provide a brief title for each table. Detailed legends should not be included under tables, but rather added into the text where applicable. The information should complement but not duplicate that already contained in the text. Use one horizontal line under the title, a second under column heads, and a third below the table, above any footnotes. Vertical and italic lines should be omitted.

Acknowledgements

Brief acknowledgements of persons who have made genuine contributions to the manuscripts and who endorse the data and conclusions should be included.

References

The author should number the references in Arabic numerals according to the citation order in the text. Put reference numbers in square brackets in superscript at the end of citation content or after the cited author’s name. When the authors write the references, please ensure that the order in the text is the same as in the references section and also ensure the spelling accuracy. Do not list the same citation twice.

1) Style for journal references

The family name of all authors should be typed with the initial letter capitalized, followed by their abbreviated first and middle initials. The title of the cited article, italicized journal title (journal title should be in its abbreviated form as shown in PubMed), publication year, volume number, start page and end page should be given sequentially.

2) Style for book references

The surname of all authors should be typed with the initial letter capitalized, followed by their abbreviated first and middle initials. Book title. Edition. Publication place: Publication press; publication year: start page and end page should be given sequentially.

Format

Jounals

English journal article (list all authors)

1 Sagoo P, Chan G, Larkin DF, George AJ. Inflammatory cytokines induce apoptosis of corneal endothelium through nitric oxide. Invest Ophthalmol Vis Sci 2004; 45:3964-3973

Chinese journal article (list all authors)

2 Jiang W, Ko WC, Hsiao SH, Chiou GCY. Effect of Z,E-butylidedephthalide on experimental choroidal neovascularization in rat and ocular blood flow in rabbits. Int J Ophthalmol (Guoji Yanke Zazhi) 2007; 7:1-5

Books

Personal author(s)

3 Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA. Medical microbiology. 4th ed. St. Louis: Mosby; 2002

Chapter in a book

4 Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein B, Kinzler KW, editors. The genetic basis of human cancer. New York: McGraw-Hill; 2002: 93-113

(Details can be seen in International Committee of Medical Journal Editors: Uniform requirements for manuscripts submitted to biomedical journals)

The manuscript which was not prepared according to this instruction will be returned to the authors without going through the review process.

Editorial Office

International Journal of Ophthalmology

No. 269 Youyi East Road

Xi’an 710054, Shaanxi Province

P.R.China

Tel: (+8629)83085628

Fax: (+8629)82245172

Email: ijo.2000@163.com   ijo2000@126.com

Website: www.ijo.cn